Show Summary Details
Page of

Anaemia management 

Anaemia management
Chapter:
Anaemia management
Author(s):

Althea Mahon

, Karen Jenkins

, and Lisa Burnapp

DOI:
10.1093/med/9780199600533.003.0010
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 25 October 2020

Introduction

Causes of anaemia

Pathophysiology

Diagnosing anaemia of chronic kidney disease

Management of anaemia

Intravenous iron

Treatment with erythropoiesis stimulating agents

Non-response/resistance to erythropoiesis stimulating agent therapy

Pure red cell aplasia

Adjuvant therapies

Patient education

Role of the healthcare professional

Further reading

Anaemia is one of the most common complications of CKD and develops early on in the disease process. Lower levels of kidney function are associated with lower Hb levels and an increased prevalence and severity of anaemia (CKD stage 3B onwards) It is also common in patients with diabetes and CKD (1 in 5 with stage 3 CKD and diabetes)....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.